Related Experiment Video
Updated: Aug 17, 2026

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages
Published on: November 3, 2014
RNA synthesis inhibition stabilises urokinase mRNA in macrophages
K J Stacey1, Y Nagamine, D A Hume
1Centre for Molecular and Cellular Biology, University of Queensland, Brisbane, Australia.
Abstract:
Urokinase-type plasminogen activator (uPA) mRNA is induced in macrophages by the lineage specific growth factor CSF-1. Upon removal of CSF-1 from bone marrow-derived macrophages (BMM), uPA mRNA decayed with a half-life of 2 h. If RNA synthesis inhibitors actinomycin D, 5,6-dichloro-1-beta-ribofuranosyl benzimidazole (DRB) or alpha-amanitin were added at the time as CSF-1 removal, the uPA message was stabilised. This was not a general effect on CSF-1 responsive mRNAs, as c-myc mRNA decayed with normal kinetics in the presence of inhibitors. The requirement for ongoing RNA synthesis for the degradation of uPA mRNA in BMM suggests that a component of the degradative pathway may be induced following removal of CSF-1.
Insights
Colony-stimulating factor 1 (CSF-1) induces urokinase-type plasminogen activator (uPA) mRNA in macrophages. Removal of CSF-1 triggers uPA mRNA decay, which requires ongoing RNA synthesis for degradation, suggesting a CSF-1-induced pathway.
Area of Science:
- Molecular Biology
- Cell Biology
- Immunology
Background:
- Macrophages play crucial roles in immunity and tissue remodeling.
- Colony-stimulating factor 1 (CSF-1) is a key regulator of macrophage proliferation, differentiation, and survival.
- Urokinase-type plasminogen activator (uPA) is a serine protease involved in extracellular matrix degradation and cell migration.
Purpose of the Study:
- To investigate the regulation of urokinase-type plasminogen activator (uPA) mRNA stability in macrophages.
- To determine the role of ongoing RNA synthesis in uPA mRNA decay following CSF-1 withdrawal.
- To elucidate the mechanisms underlying CSF-1-mediated regulation of uPA expression.
Main Methods:
- Bone marrow-derived macrophages (BMM) were cultured with or without CSF-1.
- CSF-1 was removed, and the decay kinetics of uPA mRNA were analyzed.
- RNA synthesis inhibitors (actinomycin D, DRB, alpha-amanitin) were used to assess the requirement for new RNA synthesis.
- The decay of c-myc mRNA was monitored as a control.
Main Results:
- Upon CSF-1 removal, uPA mRNA decayed with a half-life of approximately 2 hours in BMM.
- In the presence of RNA synthesis inhibitors, uPA mRNA stability was significantly increased after CSF-1 withdrawal.
- This stabilization effect was specific to uPA mRNA, as c-myc mRNA decay kinetics remained unchanged.
Conclusions:
- Ongoing RNA synthesis is required for the degradation of uPA mRNA in macrophages after CSF-1 removal.
- These findings suggest that CSF-1 withdrawal induces the synthesis of a factor that promotes uPA mRNA degradation.
- This study highlights a novel regulatory mechanism for uPA expression in macrophages, involving post-transcriptional control dependent on RNA synthesis.
Related Concept Videos
RNA Stability
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Regulation of the Unfolded Protein Response
Regulation of Expression at Multiple Steps
Inhibitors of Viral Protein Synthesis

